Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 2/20 | 0.44 |
| ▸ | DRD3 | P35462 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.38 |
| ▸ | TNF | P01375 | 2/20 | 0.38 |
| ▸ | HTR1A | P08908 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.38 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | BCHE | P06276 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL216346 | 0.84 | CNR2 (0.46) | DRD2DRD3ALDH1A1TNFNPC1 | |
| SCHEMBL7256324 | 0.81 | TNF (0.46) | DRD2DRD3LMNAALDH1A1TNF | |
| SCHEMBL16509712 | 0.80 | NPC1 (0.53) | DRD2DRD3LMNAALDH1A1TNF | |
| SCHEMBL7256567 | 0.79 | TNF (0.45) | DRD2DRD3LMNAALDH1A1TNF | |
| SCHEMBL1130229 | 0.79 | PKM (0.46) | DRD2DRD3ADORA2BTNFPTGER3 | |
| SCHEMBL7261808 | 0.78 | DRD2 (0.40) | DRD2DRD3ALDH1A1TNFNPC1 | |
| SCHEMBL14328188 | 0.77 | DRD2 (0.40) | DRD2DRD3LMNAALDH1A1TNF | |
| SCHEMBL11824740 | 0.76 | ALDH1A1 (0.44) | DRD2DRD3LMNAALDH1A1NPC1 | |
| SCHEMBL13222875 | 0.76 | TNF (0.47) | LMNATNFGRM2HDAC6 | |
| SCHEMBL12859678 | 0.76 | PARP1 (0.40) | ALDH1A1ADORA2BRAB9AMAPTHDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1763522-B1 | PYRIDIN-2-ONE COMPOUNDS AND THEIR USE AS MODULATORS OF THE DOPAMINE D3 RECEPTOR | ABBOTT GMBH & CO KG (DE) | 2013-03-20 | — | — | EP | disclosed |
| US-8334289-B2 | Pyridin-2-one compounds and their use as modulators of the dopamine D3 receptor | ABBOTT GMBH & CO. KG (DE) | 2012-12-18 | — | — | US | disclosed |
| US-8163927-B2 | Azabicyclo [3.1.0] hexane derivatives as modulators of dopamine D3 receptors | GLAXO GROUP LIMITED (GB) | 2012-04-24 | — | — | US | disclosed |
| US-8163927-B2 | Azabicyclo [3.1.0] hexane derivatives as modulators of dopamine D3 receptors | GLAXO GROUP LIMITED (GB) | 2012-04-24 | — | — | US | disclosed |
| US-8163927-B2 | Azabicyclo [3.1.0] hexane derivatives as modulators of dopamine D3 receptors | GLAXO GROUP LIMITED (GB) | 2012-04-24 | — | — | US | disclosed |
| US-20110245266-A1 | PYRIDIN-2-ONE COMPOUNDS AND THEIR USE AS MODULATORS OF THE DOPAMINE D3 RECEPTOR | ABBVIE DEUTSCHLAND GMBH & CO KG (DE) | 2011-10-06 | — | — | US | disclosed |
| US-7960386-B2 | 1-(4-{4-[2-tert-Butyl-6-(trifluoromethyl)pyrimidin-4-yl]piperazin-1-yl}butyl)-4-methylpyridin-2(1H)-one; treatment of schizophrenia and/or depression | ABBOTT GMBH & CO. KG (DE) | 2011-06-14 | — | — | US | disclosed |
| US-7928108-B2 | Pyridinone derivative for the treatment of premature ejaculation | GLAXO GROUP LIMITED (GB) | 2011-04-19 | — | — | US | disclosed |
| US-7928108-B2 | Pyridinone derivative for the treatment of premature ejaculation | GLAXO GROUP LIMITED (GB) | 2011-04-19 | — | — | US | disclosed |
| US-7928108-B2 | Pyridinone derivative for the treatment of premature ejaculation | GLAXO GROUP LIMITED (GB) | 2011-04-19 | — | — | US | disclosed |
| US-20100063097-A1 | Azabicyclo [3.1.0] Hexane Derivatives as Modulators of Dopamine D3 Receptors | GLAXO GROUP LIMITED | 2010-03-11 | — | — | US | disclosed |
| EP-2129669-A1 | PYRIDINONE DERIVATIVE FOR THE TREATMENT OF PREMATURE EJACULATION | Glaxo Group Limited (GB) | 2009-12-09 | — | — | EP | disclosed |
| EP-2010518-A1 | AZABICYCLO [3. 1. O] HEXANE DERIVATIVES AS MODULATORS OF DOPAMINE D3 RECEPTORS | GLAXO GROUP LIMITED (GB) | 2009-01-07 | — | — | EP | disclosed |
| US-20080261992-A1 | Pyridin-2-One Compounds and Their Use as Modulators of the Dopamine D3 Receptor | ABBVIE DEUTSCHLAND GMBH & CO KG (DE) | 2008-10-23 | — | — | US | disclosed |
| WO-2008122561-A1 | PYRIDINONE DERIVATIVE FOR THE TREATMENT OF PREMATURE EJACULATION | GLAXO GROUP LIMITED (GB) | 2008-10-16 | — | — | WO | disclosed |
| WO-2008122561-A1 | PYRIDINONE DERIVATIVE FOR THE TREATMENT OF PREMATURE EJACULATION | GLAXO GROUP LIMITED (GB) | 2008-10-16 | — | — | WO | disclosed |
| WO-2007113258-A1 | AZABICYCLO [3. 1. O] HEXANE DERIVATIVES AS MODULATORS OF DOPAMINE D3 RECEPTORS | GLAXO GROUP LIMITED (GB) | 2007-10-11 | — | — | WO | disclosed |
| WO-2007113258-A1 | AZABICYCLO [3. 1. O] HEXANE DERIVATIVES AS MODULATORS OF DOPAMINE D3 RECEPTORS | GLAXO GROUP LIMITED (GB) | 2007-10-11 | — | — | WO | disclosed |
| EP-1763522-A1 | PYRIDIN-2-ONE COMPOUNDS AND THEIR USE AS MODULATORS OF THE DOPAMINE D3 RECEPTOR | Abbott GmbH & Co. KG (DE) | 2007-03-21 | — | — | EP | disclosed |
| WO-2005118571-A1 | PYRIDIN-2-ONE COMPOUNDS AND THEIR USE AS MODULATORS OF THE DOPAMINE D3 RECEPTOR | ABBOTT GMBH & CO. KG (DE) | 2005-12-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110245266-A1 | PYRIDIN-2-ONE COMPOUNDS AND THEIR USE AS MODULATORS OF THE DOPAMINE D3 RECEPTOR | DRD3, DRD2, PTGDR | DRD2 2/4885DRD3 1/4885LMNA 4673/4885 |
| US-20080261992-A1 | Pyridin-2-One Compounds and Their Use as Modulators of the Dopamine D3 Receptor | DRD3, DRD2, MTNR1A | DRD2 2/4885DRD3 1/4885LMNA 4597/4885 |
| US-20100063097-A1 | Azabicyclo [3.1.0] Hexane Derivatives as Modulators of Dopamine D3 Receptors | DRD3, DRD2, DRD1 | DRD2 2/4885DRD3 1/4885LMNA 4820/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.